HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin-Hun Juang Selected Research

2,5- bis(5- hydroxymethyl- 2- selenienyl)- 3- hydroxymethyl- N- methylpyrrole

3/2007Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036.
1/2007D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin-Hun Juang Research Topics

Disease

16Neoplasms (Cancer)
03/2019 - 02/2004
8Nasopharyngeal Carcinoma
08/2022 - 07/2002
5Prostatic Neoplasms (Prostate Cancer)
02/2015 - 02/2011
4Carcinoma (Carcinomatosis)
06/2014 - 02/2005
3Renal Cell Carcinoma (Grawitz Tumor)
06/2014 - 01/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018 - 06/2014
2Colonic Neoplasms (Colon Cancer)
10/2018 - 04/2004
2T-Cell Leukemia (Leukemia, T Cell)
06/2014 - 09/2011
2Hepatocellular Carcinoma (Hepatoma)
01/2013 - 08/2012
2Hemolysis
01/2011 - 10/2009
1Infections
08/2022
1Mouth Neoplasms (Oral Cancer)
01/2015
1Fibrosarcoma
06/2014
1Leukemia
01/2014
1Disease Progression
04/2013
1Stomach Neoplasms (Stomach Cancer)
01/2013
1Hepatitis
08/2012
1Lung Neoplasms (Lung Cancer)
05/2012
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2012
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2007
1Malignant Pleural Effusion
02/2005
1Pleural Effusion (Pleural Effusions)
02/2005
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2004
1Necrosis
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
04/2004
1Glioblastoma (Glioblastoma Multiforme)
03/2004
1Glioma (Gliomas)
03/2004

Drug/Important Bio-Agent (IBA)

3CaspasesIBA
10/2015 - 04/2004
3AndrogensIBA
11/2013 - 02/2011
3Antineoplastic Agents (Antineoplastics)IBA
01/2007 - 07/2002
2Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
03/2019 - 03/2004
2Emodin (Archin)IBA
03/2019 - 01/2015
2AntioxidantsIBA
07/2015 - 01/2011
2MicroRNAs (MicroRNA)IBA
12/2014 - 02/2011
2AnthraquinonesIBA
01/2014 - 10/2009
22,2'-azobis(2-amidinopropane) (ABAP)IBA
01/2011 - 10/2009
22,5- bis(5- hydroxymethyl- 2- selenienyl)- 3- hydroxymethyl- N- methylpyrroleIBA
03/2007 - 01/2007
2Neoplasm Antigens (Tumor Antigens)IBA
02/2005 - 02/2004
1Estrogens (Estrogen)FDA Link
08/2022
1Estrogen ReceptorsIBA
08/2022
1Betulinic AcidIBA
10/2018
1tetrahydrofuranIBA
12/2016
1AcetogeninsIBA
12/2016
1Methotrexate (Mexate)FDA LinkGeneric
12/2016
16- (2- hydroxyimino- 2- (4- methoxyphenyl)ethoxy)- 2- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2015
1OximesIBA
10/2015
1flavoneIBA
10/2015
1Biomarkers (Surrogate Marker)IBA
02/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015
1liriodenineIBA
06/2014
1oliverolineIBA
06/2014
1AmidesIBA
01/2014
1xanthoneIBA
01/2014
1carbazoleIBA
01/2014
1Transcription Factors (Transcription Factor)IBA
11/2013
1NF-kappa B (NF-kB)IBA
11/2013
1Calcitriol Receptors (Calcitriol Receptor)IBA
04/2013
1methyl 4-azidophenylacetimidate (APAI)IBA
04/2013
1compound 18IBA
01/2013
1acetamideIBA
01/2013
1ajugalide-BIBA
08/2012
12,5-dichloro-4-bromophenol (B 2)IBA
05/2012
1FluorineIBA
09/2011
1fluoroform (trifluoromethane)IBA
09/2011
1Small Untranslated RNAIBA
02/2011
1Free RadicalsIBA
10/2009
1Nuclear Proteins (Protein, Nuclear)IBA
01/2007
1Phosphotransferases (Kinase)IBA
01/2007
1N-methylpyrroleIBA
01/2007
12,5- bis(4- hydroxy- 3- methoxybenzylidene)cyclopentanoneIBA
07/2004
1Propidium (Propidium Iodide)IBA
07/2004
1Annexin A5IBA
07/2004
1HLA-A*02:01 antigenIBA
04/2004
1Peptides (Polypeptides)IBA
04/2004
1Carcinoembryonic AntigenIBA
04/2004
1HLA-A Antigens (HLA-A)IBA
04/2004
1Interferon-betaIBA
04/2004
1LigandsIBA
03/2004
1Epidermal Growth Factor (EGF)IBA
03/2004
1CD40 Ligand (CD40L)IBA
02/2004
1Cancer VaccinesIBA
02/2004
1AntigensIBA
02/2004
1CamptothecinIBA
07/2002
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2002

Therapy/Procedure

6Therapeutics
12/2014 - 03/2004
3Prostatectomy (Retropubic Prostatectomy)
02/2015 - 11/2013
1Traditional Medicine (Folk Remedies)
08/2012
1Drug Therapy (Chemotherapy)
04/2004
1Aftercare (After-Treatment)
04/2004